Neurofibromatosis is a genetic disorder that causes tumors in the nervous system. Tumors develop in the nerves or the tissue that surrounds the nerves, called myelin sheath. Neurofibromatosis is divided into three types, neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. The type is determined by the specific genes that are affected.
This articles discusses NF1, the most common neurofibromatosis. It affects the nerves outside the brain and spinal cord, called peripheral nerves.
The Nervous System
Copyright © Nucleus Medical Media, Inc.
NF is caused by a change in a specific gene. The gene normally makes proteins that help control growth in the nerves. Since the gene is defective, these proteins are not able to control growth, and tumors develop.
In many cases, the abnormal gene is inherited from a parent. A person with the inherited form of NF has a 50% chance of passing the abnormal gene to each child. Any parents, children, and siblings of an affected individual should be considered at risk for NF. However, the gene change can occur in a person with no family history of NF.
Schwannomatosis—mutation of the SMARCB1/INI1 gene
The main risk factor for NF is having a family member with the disease.
Most symptoms begin between birth and age 10. NF1 may cause:
Other medical conditions that are associated with NF1 include:
The doctor will ask about your medical and family medical history. It may take a few years before NF1 is diagnosed. NF1 may be suspected if there is a history of:
A physical exam will also be done. The diagnosis is generally made based on your history, symptoms, and the physical exam. You may also been sent to specialists to look for signs of tumors of the nervous system.
An MRI scan may be done to create images of the nerves and brain to look for tumors. Samples of tumors may also be removed and sent for a biopsy.
Genetic testing may be recommended for families with a history of neurofibromatosis. Prenatal diagnosis may also be possible with amniocentesis or chorionic villus sampling.
There are no current treatments to stop these tumors from growing. Treatment may not be needed since these tumors are rarely cancerous, grow slowly and may not cause problems. Regular exams are recommended to check for new tumors or symptoms.
Treatment may be needed to control symptoms. Surgery may be done to remove painful or disfiguring tumors. Medications and therapies may also be needed to manage other symptoms such as seizures and learning disabilities.
There are no guidelines for preventing neurofibromatosis.
Children's Tumor Foundation
The British Columbia Neurofibromatosis Foundation
Neurofibromatosis. Children's Tumor Foundation website. Available at: http://www.ctf.org/Learn-About-NF/Learn-About-NF.html . Accessed October 21, 2013.
Neurofibromatosis type 1. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated August 27, 2010. Accessed October 21, 2013.
NINDS neurofibromatosis information page. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.n... . Accessed October 21, 2013.
Your Genes Your Health website. Available at: http://www.yourgenesyourhealth.org/nf/whatisit.htm . Accessed October 21, 2013.
Last reviewed August 2013 by Rimas Lukas, MD
Last Updated: 5/11/2013